Literature DB >> 2769291

Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's disease.

P Celsis, J L Montastruc, O Rascol, J M Senard, J P Marc-Vergnes, A Rascol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2769291      PMCID： PMC1031949          DOI： 10.1136/jnnp.52.7.917

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Scopolamine reduces frontal cortex perfusion.

Authors:  W G Honer; I Prohovnik; G Smith; L R Lucas
Journal:  J Cereb Blood Flow Metab       Date:  1988-10       Impact factor: 6.200

2.  [Cerebral hemodynamics and clinical pharmacology in Parkinson disease].

Authors:  J P Marc-Vergnes; P Celsis; J L Montastruc; J F Demonet; A Agniel; O Rascol; G Viallard; B Doyon; A Rascol
Journal:  Therapie       Date:  1988 Mar-Apr       Impact factor: 2.070

3.  The oculomotor behaviour of human albinos.

Authors:  H Collewijn; P Apkarian; H Spekreijse
Journal:  Brain       Date:  1985-03       Impact factor: 13.501

4.  [Effect of bromocriptine on cerebral blood flow in Parkinson's disease].

Authors:  P Celsis; O Rascol; J F Demonet; A Agniel; J L Montastruc; J P Marc-Vergnes; A Rascol
Journal:  Rev Neurol (Paris)       Date:  1988       Impact factor: 2.607

5.  Cholinergic cerebral vasodilatation in the rabbit: absence of concomitant metabolic activation.

Authors:  O U Scremin; R R Sonnenschein; E H Rubinstein
Journal:  J Cereb Blood Flow Metab       Date:  1982       Impact factor: 6.200
  5 in total
  1 in total

1.  Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.

Authors:  U Sabatini; O Rascol; P Celsis; G Houin; A Rascol; J P Marc-Vergnes; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.